These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 12234800
1. Urocortin protects the heart from reperfusion injury via upregulation of p42/p44 MAPK signaling pathway. Schulman D, Latchman DS, Yellon DM. Am J Physiol Heart Circ Physiol; 2002 Oct; 283(4):H1481-8. PubMed ID: 12234800 [Abstract] [Full Text] [Related]
2. Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart. Brar BK, Jonassen AK, Egorina EM, Chen A, Negro A, Perrin MH, Mjøs OD, Latchman DS, Lee KF, Vale W. Endocrinology; 2004 Jan; 145(1):24-35; discussion 21-3. PubMed ID: 12970163 [Abstract] [Full Text] [Related]
3. Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway. Brar BK, Jonassen AK, Stephanou A, Santilli G, Railson J, Knight RA, Yellon DM, Latchman DS. J Biol Chem; 2000 Mar 24; 275(12):8508-14. PubMed ID: 10722688 [Abstract] [Full Text] [Related]
6. Rapid mitogen-activated protein kinase by basic fibroblast growth factor in rat intestine after ischemia/reperfusion injury. Fu XB, Yang YH, Sun TZ, Chen W, Li JY, Sheng ZY. World J Gastroenterol; 2003 Jun 24; 9(6):1312-7. PubMed ID: 12800247 [Abstract] [Full Text] [Related]
7. Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury. Chai W, Wu Y, Li G, Cao W, Yang Z, Liu Z. Am J Physiol Endocrinol Metab; 2008 Jan 24; 294(1):E183-9. PubMed ID: 18003719 [Abstract] [Full Text] [Related]
8. Sustained activation of p42/p44 mitogen-activated protein kinase during recovery from simulated ischaemia mediates adaptive cytoprotection in cardiomyocytes. Punn A, Mockridge JW, Farooqui S, Marber MS, Heads RJ. Biochem J; 2000 Sep 15; 350 Pt 3(Pt 3):891-9. PubMed ID: 10970806 [Abstract] [Full Text] [Related]
9. Urocortin protects against ischemic injury via a MAPK-dependent pathway. Latchman DS. Trends Cardiovasc Med; 2001 Jul 15; 11(5):167-9. PubMed ID: 11597826 [Abstract] [Full Text] [Related]
10. Mitogenic effect of oxidized low-density lipoprotein on vascular smooth muscle cells mediated by activation of Ras/Raf/MEK/MAPK pathway. Yang CM, Chien CS, Hsiao LD, Pan SL, Wang CC, Chiu CT, Lin CC. Br J Pharmacol; 2001 Apr 15; 132(7):1531-41. PubMed ID: 11264247 [Abstract] [Full Text] [Related]
11. Cardiotrophin-1 and urocortin cause protection by the same pathway and hypertrophy via distinct pathways in cardiac myocytes. Railson JE, Liao Z, Brar BK, Buddle JC, Pennica D, Stephanou A, Latchman DS. Cytokine; 2002 Mar 07; 17(5):243-53. PubMed ID: 12027405 [Abstract] [Full Text] [Related]
13. Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via R1alpha and R2beta CRH receptor subtypes and stimulation of Gq-proteins. Grammatopoulos DK, Randeva HS, Levine MA, Katsanou ES, Hillhouse EW. Mol Endocrinol; 2000 Dec 07; 14(12):2076-91. PubMed ID: 11117536 [Abstract] [Full Text] [Related]
14. Regulation of p42/p44 MAPK and p38 MAPK by the adenosine A(1) receptor in DDT(1)MF-2 cells. Robinson AJ, Dickenson JM. Eur J Pharmacol; 2001 Feb 16; 413(2-3):151-61. PubMed ID: 11226388 [Abstract] [Full Text] [Related]
15. PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning. Mocanu MM, Bell RM, Yellon DM. J Mol Cell Cardiol; 2002 Jun 16; 34(6):661-8. PubMed ID: 12054853 [Abstract] [Full Text] [Related]
16. Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Hausenloy DJ, Tsang A, Mocanu MM, Yellon DM. Am J Physiol Heart Circ Physiol; 2005 Feb 16; 288(2):H971-6. PubMed ID: 15358610 [Abstract] [Full Text] [Related]
17. Protective effects of the urocortin homologues stresscopin (SCP) and stresscopin-related peptide (SRP) against hypoxia/reoxygenation injury in rat neonatal cardiomyocytes. Chanalaris A, Lawrence KM, Stephanou A, Knight RD, Hsu SY, Hsueh AJ, Latchman DS. J Mol Cell Cardiol; 2003 Oct 16; 35(10):1295-305. PubMed ID: 14519439 [Abstract] [Full Text] [Related]
18. Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury. Bose AK, Mocanu MM, Carr RD, Brand CL, Yellon DM. Diabetes; 2005 Jan 16; 54(1):146-51. PubMed ID: 15616022 [Abstract] [Full Text] [Related]